Ashish Kamat, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Biological Dynamics
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Urogen
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Incyte DSMB
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Theralase
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Janssen Pharmaceutical
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    ProTara
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Seattle Genetics
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Cold Genesys
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Eisai
    Date added:
    Date updated:
    10/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Biological Dynamics
    Date added:
    Date updated:
    10/10/2024

Pages

Return to Management of Non Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2021)